To expand and improve the programs and activities of the Department of Health and Human Services for awareness, education, research, surveillance, diagnosis, and treatment concerning rare diseases and conditions.
Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Rare disease Advancement, Research, and Education Act of 2018 or the RARE Act of 2018 This bill reauthorizes through FY2023 the Office of Rare Diseases in the National Institutes of Health. The bill requires (1) the Centers for Disease Control and Prevention to expand infrastructure and activities to track the epidemiology of rare diseases and conditions and to incorporate this information into a National Rare Disease or Condition Surveillance System, and (2) the Agency for Healthcare Research and Quality to expand its activities to increase providers' awareness of rare diseases and conditions.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Congressional oversightGovernment information and archivesHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsPublic-private cooperationResearch administration and fundingResearch and development
To expand and improve the programs and activities of the Department of Health and Human Services for awareness, education, research, surveillance, diagnosis, and treatment concerning rare diseases and conditions.
USA115th CongressHR-5115| House
| Updated: 3/2/2018
Rare disease Advancement, Research, and Education Act of 2018 or the RARE Act of 2018 This bill reauthorizes through FY2023 the Office of Rare Diseases in the National Institutes of Health. The bill requires (1) the Centers for Disease Control and Prevention to expand infrastructure and activities to track the epidemiology of rare diseases and conditions and to incorporate this information into a National Rare Disease or Condition Surveillance System, and (2) the Agency for Healthcare Research and Quality to expand its activities to increase providers' awareness of rare diseases and conditions.
Health Subcommittee, Energy and Commerce Committee
Health
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Congressional oversightGovernment information and archivesHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsPublic-private cooperationResearch administration and fundingResearch and development